ArticleBrain and behavior2026
Korean Red Ginseng Attenuates Dysfunctions and Modulates Inflammatory and Neuroplasticity Markers in the Harmaline-Induced Model of Essential Tremor.
Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundEssential tremor (ET) is a prevalent movement disorder characterized by tremors and other motor and nonmotor symptoms which can significantly impact daily activities and quality of life. Current therapeutic options are limited in both efficacy and tolerability. Korean red Ginseng (Panax) has demonstrated neuroprotective properties in various neurological conditions, but its potential benefits in ET remain unexplored.
methodsET was induced in male Swiss mice (n = 32) using Harmaline hydrochloride (10 mg/kg, intraperitoneal [i.p.]) administered on Days 1, 3, and 5. Korean red Ginseng (100 mg/kg) was given orally for 7 consecutive days. Motor function, anxiety-like behaviors, and cognitive performance were assessed through behavioral testing. Gene expression analysis of Pro-inflammatory mediators(TNF-α, NF-κB, IL-1β, IL-6) and neuroplasticity markers (Lingo-1, NMDA) were performed in cerebellar tissue through RT-qPCR.
resultsKorean red Ginseng significantly attenuated Harmaline-induced tremor severity and improved motor coordination on the rotarod test. Treatment also ameliorated anxiety-like behaviors and fear-associated memory deficits in Harmaline-treated mice. At the molecular level, Korean red Ginseng suppressed Harmaline-induced elevations in pro-inflammatory markers (TNF-α, NF-κB, IL-1β, IL-6) and normalized the expression of Lingo-1 and NMDA receptor genes in the cerebellum.
conclusionsKorean red Ginseng ameliorated both motor and nonmotor symptoms in an animal model of ET potentially through modulation of neuroinflammatory and neuroplasticity pathways. These findings suggest that Korean red Ginseng may represent a promising therapeutic option for ET management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.